Which specific requirements apply to GMP-compliant documentation and validatable cleaning in pharmaceutical mixing processes?
Pharmaceutical mixing processes are critical manufacturing steps, because they largely determine homogeneity, active ingredient distribution and thus the quality and safety of the end product. The requirements for GMP-compliant documentation and validatable cleaning are correspondingly strict, oriented to the EU GMP Guide, to FDA requirements and to the relevant ICH guidelines.
Requirements for GMP-compliant documentation
The aim of documentation is complete, traceable and always verifiable traceability of all process-relevant activities.
Good documentation practice and ALCOA+
GMP-compliant documentation follows the principles of good documentation practice and the ALCOA+ principles: attributable, legible, contemporaneous, original, accurate as well as complete, consistent, enduring and available.
For mixing processes this means in particular:
- Complete recording of critical process parameters such as mixing time, rotational speed, temperature, pressure, fill level and vacuum.
- Contemporaneous entry of the data directly during or immediately after the operation.
- Legible, unambiguous and unalterable entries with date and signature.
- Traceable corrections in which the original entry remains recognisable.
Batch-specific traceability
A unique history is required for every batch. This includes complete manufacturing and testing records, allocation to product, batch size and equipment used as well as documentation of weighings, process steps, in-process controls, deviations and CAPA measures.
Separation of specification and evidence
GMP documents can be divided into specification documents and records. Specifications include SOPs, manufacturing instructions, cleaning instructions and qualification and validation plans. Records include batch records, test results, qualification and validation reports and audit trail logs.
Qualification and validation documentation
The documentation must demonstrate that the mixer is operated in a qualified and validated state. This includes URS, DQ, IQ, OQ and PQ, and also FAT and SAT protocols, change management and evidence of process validation through defined validation batches with established acceptance criteria.
Electronic documentation and data integrity
With electronic systems, additional requirements apply to electronic signatures, audit trail and access control. Data must remain secure, complete, traceable and available throughout their entire lifetime.
Requirements for validatable cleaning
The aim of cleaning validation is documented evidence that the defined cleaning procedure reproducibly reduces residues to an acceptable level and prevents cross-contamination.
Cleaning validation and evidence
Validated cleaning comprises a clearly defined cleaning procedure with established detergents, concentrations, temperatures, contact times and flow conditions. Cleaning success must be demonstrated reproducibly, usually over several consecutive successful cleaning cycles.
Sampling and analysis
Typical methods are swab samples for areas that are difficult to access, rinse samples for large or complex geometries and validated analytical procedures for detecting active ingredient residues, detergent residues and microbiological load.
Acceptance criteria and MACO
The permissible residue limits are established via the MACO and are today derived predominantly on a risk basis from health-based exposure limits or PDE values. In addition, company-internal limits such as 10 ppm or visual cleanliness can be used as criteria.
Worst-case and bracketing approaches
Risk-based strategies are used in order to limit the validation effort in multi-product plants. The most difficult product, the most critical part of the plant or a representative product group is frequently taken as the worst case.
Design and technical prerequisites
Validatable cleaning presupposes a hygienic plant concept. This includes product-contact surfaces of suitable material quality with low roughness, resistant seals and a geometry without dead spaces, gaps or blind holes.
Good accessibility, complete drainability and suitable CIP capability with demonstrable wetting of all relevant surfaces are also important. The effectiveness of cleaning should be monitored and documented technically, for example by measuring temperature, pressure, flow and conductivity.
Avoiding cross-contamination
To avoid cross-contamination, the campaign concept, the product criticality and the containment level must also be taken into account. With highly active ingredients or sensitive products, dedicated plants or particularly strict cleaning and safety concepts may be necessary.
The essential point
GMP-compliant documentation in pharmaceutical mixing processes means the complete, ALCOA+-compliant recording of all qualification, validation and batch-related information. Validatable cleaning rests on a risk-based cleaning and design concept with demonstrably effective, reproducible and regulatorily assured reduction of product and detergent residues.
How amixon® supports validatable cleaning and its documentation
A design that makes validation possible
A cleaning validation is only as good as the accessibility of the plant. At amixon®, large Clever-Cut® inspection doors with the OmgaSeal® seal provide complete, ergonomic access to all product-contact surfaces. This facilitates swab sampling at worst-case points as well as visual inspection.
Because the mixing chamber and mixing tool are welded free of crevices and ground smooth and the mixing tool is supported only at the top, there are structurally no hidden sampling risk points such as gaps, lower shaft passages or dead spaces.
The integrated washing lances are programmable target-jet cleaners. Together with WaterDragon® they allow defined, reproducible CIP and WIP cycles; rinse samples can be taken at the dead-space-free outlet. SinConcave® and SinConvex® helical mixing tools have a strong self-cleaning effect and promote residual discharge of 99.997 % and better with free-flowing materials. This lowers the initial soil load of every cleaning cycle and reduces the consumption of wash water as well as the effluent.
Qualification in accordance with recognised regulations
amixon® assists on request with DQ, IQ and OQ. Documentation and execution follow, on request, EU GMP and FDA 21 CFR Part 11; integration follows the operator's validation concept from the URS through to commissioning. Every apparatus is a documented one-off from in-house manufacture in Paderborn, so that material certificates, surface specifications and welding documentation are available without gaps.
Reproducible operation as the basis for validation
Mixing and cleaning programmes can be stored in the control system and documented batch by batch. Cleaning cycles can thus be evidenced traceably. Limits, analysis such as swab or rinse tests and acceptance criteria are defined by the operator; amixon® supplies the plant that can be qualified for this purpose and, on request, tests cleaning regimes in advance at the pilot plant with the original product.
Particularly suitable for pharmaceutical applications
For pharmaceutical applications, amixon® supplies the apparatus in GMP-compliant form, on request usable in FDA-compliant form as sterile mixers and reactors as well as EHEDG- and 3-A-compliant.
Manufacture in Paderborn as the quality foundation
amixon® develops and manufactures exclusively at the Paderborn works with a high depth of manufacture and all components from Germany. As a certified welding company with European, Japanese, Korean and American qualifications, amixon® designs every apparatus as a one-off on the basis of the operator's URS; quality control remains entirely in-house without gaps, and every specification is verifiable down to component level. This manufacturing autonomy also secures long-term supply: every component can still be re-manufactured reproducibly decades later.